Why Investors are Pushing Into Psychedelic Stocks
Psilocybin has made major headlines over the last few days. Not only was it legalized in Oregon and Washington, D.C.,
Read more
Consumer
Wearable Tech an $81.5 Billion Opportunity
Now more than ever health and wellness are top priorities, creating big opportunity for companies such as Hapbee Technologies, Inc.
Read more
Testing Economy a $157 Billion Market
Pandemic testing has become the new norm. “We’ve gone from 1 million to 4.5 million tests per week in the
Read more
New Vaccine from Johnson & Johnson a Game-Changer
The fight against the health pandemic continues. We already have vaccines from Pfizer (NYSE:PFE), BioNTech (NASDAQ:BNTX), and Moderna Inc. (NASDAQ:MRNA). Johnson & Johnson’s (NYSE:JNJ) vaccine is reportedly effective,
Read more
Cannabis Reform Could Get a Major Boost
As legal cannabis goes mainstream, it’s finding its way into a good deal of medical, beauty, and even recreational products.
Read more
CBD Beverages Creating Tremendous Opportunity
CBD-infused beverages are quickly gaining traction in the cannabis industry. Tilray Inc. (NASDAQ:TLRY), which announced plans to merge with Aphria,
Read more
The Sky’s the Limit for Drones with the FAA
Commercial drone delivery has gone global. Plus, with the U.S. Federal Aviation Administration set to relax certain restrictions for drones
Read more
Probiotics a $64.02 Billion Opportunity
The probiotics market could become a $64.02 billion market by 2022. All thanks to growing consumer awareness of its benefits,
Read more
New Psychedelics ETF to Launch this Week
Psychedelics are going mainstream. Not only is the US FDA supportive of research, dozens of medical studies are proving such
Read more
Pay Close Attention to AR in 2021
Augmented reality has only just begun to revolutionize life and business as we know it. For example, such technology allows
Read more